Salicyl alcoholCAS# 90-01-7 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 90-01-7 | SDF | Download SDF |
| PubChem ID | 5146 | Appearance | Powder |
| Formula | C7H8O2 | M.Wt | 124.1 |
| Type of Compound | Phenols | Storage | Desiccate at -20°C |
| Synonyms | 2-Hydroxybenzyl alcohol; Saligenin | ||
| Solubility | DMSO : ≥ 100 mg/mL (805.54 mM) H2O : 33.33 mg/mL (268.49 mM; Need ultrasonic) *"≥" means soluble, but saturation unknown. | ||
| Chemical Name | 2-(hydroxymethyl)phenol | ||
| SMILES | C1=CC=C(C(=C1)CO)O | ||
| Standard InChIKey | CQRYARSYNCAZFO-UHFFFAOYSA-N | ||
| Standard InChI | InChI=1S/C7H8O2/c8-5-6-3-1-2-4-7(6)9/h1-4,8-9H,5H2 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | Benzyl and salicyl alcohol, the local anesthetics, are effective inhibitors of lymphocyte-mediated cytolysis (LMC) in vitro. |
| In vitro | Inhibition of lymphocyte-mediated cytolysis by the local anesthetics benzyl and salicyl alcohol[Reference: WebLink]European Journal of Immunology ,2010 ,3 (11) :674-7.The local anesthetics, benzyl and Salicyl alcohol, are effective inhibitors of lymphocyte-mediated cytolysis (LMC) in vitro.
|
| In vivo | Synthetically modified bioisosteres of salicyl alcohol and their gastroulcerogenic assessment versus aspirin: biochemical and histological correlates.[Pubmed: 24292286]Naunyn Schmiedebergs Arch Pharmacol. 2014 Mar;387(3):281-90.The present study was conducted to synthesize nitrogen containing derivatives of Salicyl alcohol and to investigate in vivo their ulcerogenic potential in comparison with aspirin in rats. |
| Animal Research | Comparative evaluation of gastroulcerogenic potential of nitrogen isoforms of salicyl alcohol and aspirin in rats: biochemical and histological study.[Pubmed: 24085627]Arch Pharm Res. 2014 Jul;37(7):916-26.The aim of the current study was to explore in vivo any relative gastroulcerogenic prospective propensity of newly synthesized nitrogen containing derivatives of Salicyl alcohol; compound (I) [1-(2-hydroxybenzyl)piperidinium chloride], compound (II) [4-carbamoyl-1-(2-hydroxybenzyl)piperidinium chloride] and aspirin in albino rats.
|
Salicyl alcohol Dilution Calculator
Salicyl alcohol Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 8.058 mL | 40.2901 mL | 80.5802 mL | 161.1604 mL | 201.4504 mL |
| 5 mM | 1.6116 mL | 8.058 mL | 16.116 mL | 32.2321 mL | 40.2901 mL |
| 10 mM | 0.8058 mL | 4.029 mL | 8.058 mL | 16.116 mL | 20.145 mL |
| 50 mM | 0.1612 mL | 0.8058 mL | 1.6116 mL | 3.2232 mL | 4.029 mL |
| 100 mM | 0.0806 mL | 0.4029 mL | 0.8058 mL | 1.6116 mL | 2.0145 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Salicyl alcohol is an intermediate for medicine, perfume, pesticide.
- 3-(Hydroxymethyl)-3-nitro-1-(4-octylphenyl)-1,4-butanediol
Catalog No.:BCN1313
CAS No.:899822-99-2
- 3-Nitro-1-(4-octylphenyl)-1-propanone
Catalog No.:BCN2250
CAS No.:899822-97-0
- CC-930
Catalog No.:BCC1459
CAS No.:899805-25-5
- ML 348
Catalog No.:BCC5611
CAS No.:899713-86-1
- A 438079
Catalog No.:BCC1316
CAS No.:899507-36-9
- Platycoside K
Catalog No.:BCN3242
CAS No.:899447-64-4
- A 438079 hydrochloride
Catalog No.:BCC1317
CAS No.:899431-18-6
- Gymnoside III
Catalog No.:BCN8218
CAS No.:899430-03-6
- Beta-Carboline-1-propanoic acid
Catalog No.:BCN5805
CAS No.:89915-39-9
- 3-O-Acetyl-alpha-boswellic acid
Catalog No.:BCN2671
CAS No.:89913-60-0
- 3-Epichromolaenide
Catalog No.:BCN7241
CAS No.:89913-53-1
- 4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one hydrochloride
Catalog No.:BCC8647
CAS No.:898543-06-1
- Guaiacol
Catalog No.:BCN8311
CAS No.:90-05-1
- 1-Naphthol
Catalog No.:BCC8473
CAS No.:90-15-3
- beta-Rhamnocitrin
Catalog No.:BCN3293
CAS No.:90-19-7
- Xanthoxylin
Catalog No.:BCN4443
CAS No.:90-24-4
- 4-Methylumbelliferone
Catalog No.:BCN2563
CAS No.:90-33-5
- Xanthone
Catalog No.:BCC6493
CAS No.:90-47-1
- 3,4,5-Trimethoxycinnamic acid
Catalog No.:BCN5030
CAS No.:90-50-6
- 6-Amino-4-hydroxy-2-naphthalenesulfonic acid
Catalog No.:BCC8761
CAS No.:90-51-7
- Lobelin
Catalog No.:BCN2157
CAS No.:90-69-7
- 4,4'-Bis(diethylamino)benzophenone
Catalog No.:BCC8659
CAS No.:90-93-7
- Boc-Ser(PO3Bzl2)-OH
Catalog No.:BCC3443
CAS No.:90013-45-9
- PIK-293
Catalog No.:BCC4994
CAS No.:900185-01-5
Comparative evaluation of gastroulcerogenic potential of nitrogen isoforms of salicyl alcohol and aspirin in rats: biochemical and histological study.[Pubmed:24085627]
Arch Pharm Res. 2014 Jul;37(7):916-26.
The aim of the current study was to explore in vivo any relative gastroulcerogenic prospective propensity of newly synthesized nitrogen containing derivatives of Salicyl alcohol; compound (I) [1-(2-hydroxybenzyl)piperidinium chloride], compound (II) [4-carbamoyl-1-(2-hydroxybenzyl)piperidinium chloride] and aspirin in albino rats. The experimental groups received the following oral treatments daily for 6 days: group I saline control; group II, standard (aspirin) treatment group [150 mg/kg of body weight]; group III, test (compound I) treatment group [100, 150 mg/kg]; group IV, test (compound II) treatment group [100, 150 mg/kg]. The results showed that in the case of the aspirin treated group and compound (I) [150 mg/kg], there was a significant increase in gastric volume, free acidity, total acidity, ulcer score and a decrease in gastric pH. Furthermore, histopathological examination of gastric mucosa of these treated groups revealed detectable morphological changes. Utilizing the same protocol, synthetic compound (I) [100 mg/kg] and (II) [100, 150 mg/kg] exhibited no statistically significant ulcerogenic or cytotoxic properties. A cyclooxygenase (COX) selectivity test indicated the preferential inhibition of COX-I and COX-II enzymes by compounds (I) and (II). This study therefore indicates that these synthetic compounds may possess reduced ulcerogenic potential and could be a functional substitute to aspirin.
Synthetically modified bioisosteres of salicyl alcohol and their gastroulcerogenic assessment versus aspirin: biochemical and histological correlates.[Pubmed:24292286]
Naunyn Schmiedebergs Arch Pharmacol. 2014 Mar;387(3):281-90.
The present study was conducted to synthesize nitrogen containing derivatives of Salicyl alcohol and to investigate in vivo their ulcerogenic potential in comparison with aspirin in rats. The compounds [4-(2-hydroxybenzyl) morpholin-4-iumchloride (I)] and [1,4-bis(2-hydroxybenzyl) piperazine-1,4-diium chloride (II)] were synthesized and their chemical structures were characterized using spectral data. In our previous study (Ali et al., Afr J Pharm Pharmacol 7:585-596, 2013), both compounds showed anti-inflammatory, antinociceptive, and antipyretic properties in standard animal models and a greater binding affinity for cyclooxygenase-2 versus cyclooxygenase-1 in molecular docking and dynamics analysis. For in vivo studies, animals were randomly divided into four groups. The synthetic compounds (both at 100 or 150 mg/kg), aspirin (150 mg/kg), or saline vehicle was administered orally, once daily for 6 days and then tested for ulcerogenic activity. At the end of the procedure, gastric juice and tissues were collected and subjected to biochemical and histological analyses. The results of the study revealed that in the case of the aspirin-treated group, there was a significant increase in gastric juice volume, free acidity, total acidity, and ulcer score and a decrease in gastric pH. Moreover, histological examination of the gastric mucosa of the aspirin-treated group indicated morphological changes while neither of the synthetic compounds showed any significant ulcerogenic or cytotoxic properties. The results of the present study suggest that both compounds are free from ulcerogenic side effects and may represent a better alternative to aspirin.
